Portfolio company
Tengion Inc
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This regenerative medicine company develops replacement organs and tissues using a patient's own cells for individuals with urologic, renal, gastrointestinal, and vascular diseases.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Trestle Biotherapeutics
This company develops implantable bioengineered kidney tissues to restore renal function for patients suffering from end-stage renal disease.
CuroTis
This biotechnology company develops regenerative grafts that stimulate the body to grow patient-specific blood vessels for individuals requiring vascular access or organ regeneration.
ReproGo
This regenerative medicine company develops stem cell-derived vascular cells and organoids for drug screening and treating chronic wounds and cardiovascular diseases.
eGenesis
This company develops genetically engineered pig organs for patients suffering from organ failure and requiring transplantation.
Viacyte
This regenerative medicine company develops stem cell-derived islet replacement therapies for patients living with type 1 diabetes.
Dimension Bio
This company develops 3D-printed regenerative implants and tissue-like therapies to restore organ and tissue function for patients with disease, trauma, or ageing.
LyGenesis
LyGenesis develops regenerative cell therapies that use lymph nodes as bioreactors to grow functioning organs for patients with end-stage organ failure.
BE Therapeutics
This company develops engineered brain and spinal cord tissues to repair central nervous system damage for patients with neurodegeneration, stroke or trauma.
